EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Pharmacogenetic insights into ABCB1, ABCC2, CYP1A2, and CYP2B6 variants with epilepsy susceptibility among Egyptian Children: A retrospective case-control study

Zeinab R Attia, Mariam E Labib, Ayda K Kelany, Rasha M Alnefaie, Hosam Abd Twab, Eman Wahsh, Rania A Abd El Azeem, Esraa Ibrahim A Shaaban, Afaf M Elsaid, Adel I Alalawy, Rami M Elshazli, Noha El Tantawi

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.113073 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Zeinab R Attia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Mansoura University Children's Hospital, Mansoura University, Mansoura 35516, Egypt. Hauptthemen laut MEDLINE: Multidrug Resistance-Associated Protein 2, Epilepsy, Genetic Predisposition to Disease, ATP Binding Cassette Transporter, Subfamily B. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 102 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pediatric epilepsy is a complicated neuropsychiatric disorder that is characterized by recurrent seizures and unusual synchronized electrical activities within brain tissues. It has a substantial effect on the quality of life of children, thus understanding of the hereditary considerations influencing epilepsy susceptibility and the response to antiepileptic medications is crucial. This study focuses on assessing the correlation of the ABCB1, ABCC2, CYP1A2, and CYP2B6 genetic polymorphisms with the susceptibility to epileptic seizures and their contributions to antiepileptic medication throughout the course of the disease. METHODS: This study included 134 Egyptian epileptic children, comprising 67 drug-responsive and 67 drug-resistant patients, along with 124 healthy controls matching for age, gender, and geographical district. Genotyping of the rs2032582, rs717620, rs2273697, rs762551, and rs3745274 variants was performed using the PCR technique. Statistical analyses, including haplotype, multivariate, logistic regression, and bioinformatics approaches, were conducted to evaluate the associations within the disease. RESULTS: The ABCC2*rs717620 (T allele) revealed an increased risk of epilepsy compared to healthy controls (OR = 2.12, p-value 0.05). CONCLUSIONS: The findings of our study emphasize the importance of pharmacogenetic screening in epilepsy research, particularly regarding to drug-resistant patients. The ABCC2*rs717620 variant conferred a significant correlation with elevated risk of epileptic seizures, while the ABCC2*rs2273697 and CYP1A2*rs762551 variants confirmed their contributions as protective markers against epilepsy development. Conversely, the ABCB1*rs2032582 and CYP2B6*rs3745274 alleles were not considered as independent risk factors with the course of epilepsy disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multidrug Resistance-Associated Protein 2EpilepsyGenetic Predisposition to DiseaseATP Binding Cassette Transporter, Subfamily BATP-Binding Cassette, Sub-Family C ProteinsAnticonvulsantsCytochrome P-450 CYP2B6Polymorphism, Single NucleotideHumansMaleFemaleEgyptChildCase-Control StudiesRetrospective StudiesChild, PreschoolAdolescentGenotypeHaplotypesPharmacogenetics

Stichwörter der Autor:innen

ATP binding cassettesCytochrome P450 superfamilyEpileptic seizuresGenetic variants

Substanzen

Multidrug Resistance-Associated Protein 2ATP Binding Cassette Transporter, Subfamily BATP-Binding Cassette, Sub-Family C ProteinsAnticonvulsantsCytochrome P-450 CYP2B6ABCC2 protein, humanABCB1 protein, humanCYP2B6 protein, human

Autor:innen und Institutionen

  • Mansoura University Children's Hospital, Mansoura University, Mansoura 35516, Egypt.
  • Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.
  • Department of Genomic Medicine, Cairo University Hospitals, Cairo University, Giza 12613, Egypt; Applied Science Research Center, Applied Science Private University, Amman 11831, Jordan; MEU Research Unit, Middle East U…
  • Department of Biology, Faculty of Science, Al-Baha University, Al-Baha 65779, Saudi Arabia.
  • Clinical Immunology Unit, Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Sinai University, Arish 45511, Egypt.

Zitieren

APA

Attia, Z. R., Labib, M. E., Kelany, A. K., Alnefaie, R. M., Twab, H. A., Wahsh, E., Abd El Azeem, R. A., Shaaban, E. I. A., Elsaid, A. M., Alalawy, A. I., Elshazli, R. M., & El Tantawi, N. (2024). Pharmacogenetic insights into ABCB1, ABCC2, CYP1A2, and CYP2B6 variants with epilepsy susceptibility among Egyptian Children: A retrospective case-control study. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113073

Vancouver

Attia ZR, Labib ME, Kelany AK, Alnefaie RM, Twab HA, Wahsh E, et al. Pharmacogenetic insights into ABCB1, ABCC2, CYP1A2, and CYP2B6 variants with epilepsy susceptibility among Egyptian Children: A retrospective case-control study. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113073

BibTeX
@article{Attia2024,
  author = {Attia, Zeinab R and Labib, Mariam E and Kelany, Ayda K and Alnefaie, Rasha M and Twab, Hosam Abd and Wahsh, Eman and Abd El Azeem, Rania A and Shaaban, Esraa Ibrahim A and Elsaid, Afaf M and Alalawy, Adel I and Elshazli, Rami M and El Tantawi, Noha},
  title = {Pharmacogenetic insights into ABCB1, ABCC2, CYP1A2, and CYP2B6 variants with epilepsy susceptibility among Egyptian Children: A retrospective case-control study},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.113073}
}
Kostenlos starten →